Coralville-based Viewpoint Molecular Targeting, a radiopharmaceutical company developing alpha-particle therapies and diagnostic imaging agents, is expected to merge with Isoray Inc., a medical technology company specializing in seed brachytherapy and headquartered in Richland, Washington. According to the terms of the…